Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,
Clinical trial NCT01526889 · COMPLETED
Trial details
- NCT number
- NCT01526889
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-20
- Primary completion
- 2017-02-16
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.